Echinocandin Vs fluconazole step down in patients with candida glabrata candidaemia?
🆕💫Retrospective,single-centre cohort study #JAC
No significant difference in treatment duration,incidence of persistent candidaemia or 30d clinical failure between 2 gps
https://t.co/D09j4Ubexd
Tazobactam does not inhibit AmpC-mediated hydrolysis of TOL and demonstrates poor binding affinity for both wild-type and mutant AmpC enzymes
🆕💫 #AAC
Restoring ceftolozane susceptibility: a role for diazabicyclooctane β-lactamase inhibitors #idxposts
https://t.co/Bu6LtNeGCJ
**Starting 2025 with a key update:
The new ATS/CDC/ERS/IDSA guidelines on treating drug-susceptible and drug-resistant tuberculosis (TB) are out!
What do you think about these changes? How will they shape clinical practice moving forward?**
#idxposts
In the context of emergence of cefiderocol resistance and of limited therapeutic options, the in vitro determination of cefiderocol susceptibility with a robust method is essential!
🆕💫Cefiderocol susceptibility testing: the challenge of disc diffusion
https://t.co/ZVh0AEL2a8
🔹Penicillin Binding Proteins🔹
⚡ Enterococci are relatively resistant to cephalosporins since Cps act through PBP2/3 while Enterococci use PBP4/5
⚡ MRSA are resistant to anti-Staph Penicillins by altering PBP2 ➡️ PBP2a through mecA/C
#MedTwitter#IDTwitter#JustIDThings
AmpC-producing Enterobacterales:
Expected phenotypes for wild-type strains and in cases of AmpC derepression and ESBL production
https://t.co/oQUPCAuoWO
🫀New Dukes criteria for Infective endocarditis
✅ E. faecalis is classified as a typical cause of IE
✅Inclusion of cardiac CT/PET for IE diagnosis
✅Surgical inspection of cardiac valve included as major clinical criteria
Day 4 #WAAW2024
50% all antibiotic prescriptions are unecessary.
Time to hold prescribers accountable:
[RE] EDUCATE - yourself & remember what antibiotics are used for
ADVOCATE - for proper use
ACT NOW - be accountable change your role from driving to mitigating this crisis
This week is World AMR Awareness Week. We can all play a part in the fight against #AntimicrobialResistance. If you're prescribed antibiotics:
Don't save them for later 💊
Take them as directed 👩⚕️
Don't take them for colds and flu 🚫
#WAAW
Fantastic 🆕️🔥Review by @SIDPharm 🌟 @ChrissKonig@PharmacoJournal
Evolving resistance landscape in gram-negative pathogens: An update on β-lactam and β-lactam-inhibitor treatment combinations for carbapenem-resistant organisms
@Inox94 🙏 #idxposts
https://t.co/iVWL2cLaBD
No evidence of difference in mortality with amoxicillin versus co-amoxiclav for hospital treatment of community-acquired pneumonia - Journal of Infection https://t.co/2gl5uppLIl
Lets talk about Antibiotic PK. This week's 🧵: Distribution!
This is where the drug goes after it's absorbed/injected. Where it goes = what target sites it can be used at.
Main drug factors: Hydrophilic vs Lipophilic, plasma protein binding, and peripheral tissue binding
1/9
Is de-escalation from echinocandins to azoles a safe strategy in patients with candidemia?
🆕️🔥Systematic review & meta-analysis evaluating the clinical outcomes of antifungal early DES (<7d) in Candida infections in a relatively large sample size
https://t.co/OZyAegY72R
How many nurse hours could your Trust release on introducing an effective #IVOS pathway?
The numbers are eye watering, take a look!👇🏻
#BSACWinterConference